Algorae Pharmaceuticals Limited has released a press release.
NTCELL Project Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Quarterly Activities Report/Appendix 4C Cash Flow Statement
- Agreement with HL Pharma Addendum
- Algorae to list existing Option series on ASX
- 1AI commences AI-168 pre-clinical studies
- Addendum to September Quarterly Report
Later from Algorae Pharmaceuticals
- Response to ASX Price Query
- Artificial Intelligence Platform Update
- Positive results from AI-116 in vitro studies
- AlgoraeOS Artificial Intelligence Platform Launched
- 24 New AI-Generated Drug Targets
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals